You are here

  • Home
  • Archive
  • Volume 59, Issue 7
  • Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables

Citation Tools

Article menu
Download PDFPDF
Original article
Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cross SS, Harrison RF, Balasubramanian SP, et al
Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables
Journal of Clinical Pathology 2006;59:716-720.